GENETIC EVIDENCE FOR THE EXISTENCE OF SUBGROUPS OF THE SCHIZOPHRENIC SYNDROMECANCRO R.1979; SCHIZOPHR. BULL.; USA; DA. 1979; VOL. 5; NO 3; PP. 453-459; BIBL. 22 REF.Article

ANNUAL REVIEW OF THE SCHIZOPHRENIC SYNDROME 1972CANCRO R.1972; ANNU. REV. SCHIZOPHR. SYNDROME; G.B.; DA. 1972; VOL. 2; PP. (524P.); BIBL. DISSEM.Article

GENETICS, DUALISM, AND SCHIZOPHRENIA. = GENETIQUE, DUALISME ET SCHIZOPHRENIECANCRO R.1975; J. AMER. ACAD. PSYCHOANAL.; U.S.A.; DA. 1975; VOL. 3; NO 4; PP. 353-360Article

COMPREHENSIVE THERAPY OF THE SCHIZOPHRENIC SYNDROME.CANCRO R.1976; CURR. PSYCHIATR. THERAP.; U.S.A.; DA. 1976; VOL. 16; PP. 91-100; BIBL. 13 REF.Article

THE BAD TRIP: AN EPIDEMIOLOGICAL SURVEY OF YOUTHFUL HALLUCINOGEN USE.RUBINOW DR; CANCRO R.1977; J. YOUTH ADOLESC.; G.B.; DA. 1977; VOL. 6; NO 1; PP. 1-9; BIBL. 9 REF.Article

ANNUAL REVIEW OF THE SCHIZOPHRENIC SYNDROME. 1976-1977CANCRO R ED.1976; ANNU. REV. SCHIZOPHR. SYNDROME; GBR; DA. 1976-1977 PUBL. 1978; VOL. 5; 657 P.; BIBL. DISSEM.Serial Issue

Individual psychotherapy in the treatment of chronic schizophrenic patientsCANCRO, R.American journal of psychotherapy. 1983, Vol 37, Num 4, pp 493-501, issn 0002-9564Article

PHARMACOTHERAPY OF HISPANIC DEPRESSED PATIENTS: CLINICAL OBSERVATIONSMARCOS LR; CANCRO R.1982; AM. J. PSYCHOTHER.; ISSN 0002-9564; USA; DA. 1982; VOL. 36; NO 4; PP. 505-512; BIBL. 23 REF.Article

MEDICAL AND LEGAL IMPLICATIONS OF SIDE EFFECTS FROM NEUROLEPTIC DRUGS: A ROUND-TABLE DISCUSSIONCANCRO R; DAVIS JM; KLAWANS H et al.1981; J. CLIN. PSYCHIATRY; ISSN 0160-6689; USA; DA. 1981; VOL. 42; NO 2; PP. 78-82Article

REACTION TIME AND PROGNOSIS IN ACUTE SCHIZOPHRENIA.CANCRO R; SUTTON S; KERR J et al.1973; ANNU. REV. SCHIZOPHR. SYNDROME; GBR; DA. 1973 PUBL. 1974; PP. 484-496; BIBL. 1 P. 1/2Article

Interpersonal relatdness and paranoid schizophreniaSOBEL, W; WOLSKI, R; CANCRO, R et al.The American journal of psychiatry. 1996, Vol 153, Num 8, pp 1084-1087, issn 0002-953XArticle

Brain metabolism in patients with schizophrenia before and after acute neuroleptic administrationVOLKOW, N. D; BRODIE, J. D; WOLF, A et al.Journal of neurology, neurosurgery and psychiatry. 1986, Vol 49, Num 10, pp 1199-1202, issn 0022-3050Article

Neurometric-quantitative EEG as a diagnostic adjunct in clinical psychiatryMAS, F; PRICHEP, L. S; CANCRO, R et al.European psychiatry. 1991, Vol 6, Num 3, pp 131-139Article

Low frontal glucose utilization in chronic schizophrenia: a replication studyWOLKIN, A; ANGRIST, B; WOLF, A et al.SMPTE journal (1976). 1988, Vol 145, Num 2, pp 251-253, issn 0036-1682Article

Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomographyWOLKIN, A; ANGRIST, B; WOLF, A et al.Psychopharmacologia. 1987, Vol 92, Num 2, pp 241-246, issn 0033-3158Article

Quantitative EEG correlates of cognitive deterioration in the elderlyPRICHEP, L. S; JOHN, E. R; FERRIS, S. H et al.Neurobiology of aging. 1994, Vol 15, Num 1, pp 85-90, issn 0197-4580Article

Electrophysiological subtypes of psychotic statesJOHN, E. R; PRICHEP, L. S; WINTERER, G et al.Acta psychiatrica Scandinavica. 2007, Vol 116, Num 1, pp 17-35, issn 0001-690X, 19 p.Article

Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patientsSERPER, M. R; BERGMAN, A; COPERSINO, M. L et al.Psychiatry research. 2000, Vol 93, Num 1, pp 21-32, issn 0165-1781Article

Phenomenological correlates of metabolic activity in 18 patients with chronic schizophreniaVOLKOW, N. D; WOLF, A. P; VAN GELDER, P et al.The American journal of psychiatry. 1987, Vol 144, Num 2, pp 151-158, issn 0002-953XConference Paper

Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and ¹¹C-raclopride in normal human subjectsSMITH, G. S; SCHLOESSER, R; CANCRO, R et al.Neuropsychopharmacology (New York, NY). 1998, Vol 18, Num 1, pp 18-25, issn 0893-133XArticle

Diminished cerebral metabolic response to motor stimulation in schizophrenics : a PET studyGUENTHER, W; BRODIE, J. D; BARTLETT, E. J et al.European archives of psychiatry and clinical neuroscience. 1994, Vol 244, Num 3, pp 115-125, issn 0940-1334Article

Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patientsBARTLETT, E. J; BRODIE, J. D; SIMKOWITZ, P et al.The American journal of psychiatry. 1998, Vol 155, Num 3, pp 337-343, issn 0002-953XArticle

Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjectsBARTLETT, E. J; BRODIE, J. D; CANCRO, R et al.The American journal of psychiatry. 1994, Vol 151, Num 5, pp 681-686, issn 0002-953XArticle

Assessment of the Safety and Efficacy data for the hypnotic Halcion®: Results of an analysis by an Institute of medicine committeeGIBBONS, R. D; BROWN, B. W. M; STOLLEY, P. D et al.Journal of the American Statistical Association. 1999, Vol 94, Num 448, pp 993-1002, issn 0162-1459Article